Stock Information
Aktis Oncology Inc (AKTS)
Ticker Symbol: AKTS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,413.72 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.6351
Revenue (TTM): $0.20 M
Dividend Yield: N/A%
ROE: -47.5297%
Latest News
-
JP Morgan Maintains Overweight on Aktis Oncology, Raises Price Target to $33
Tue, Jul 14, 2026 9:43 AM
Key Financials
Financial data not available